Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Merck
Dow
AstraZeneca
Johnson and Johnson

Last Updated: June 28, 2022

CLINICAL TRIALS PROFILE FOR ALBUTEROL SULFATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for albuterol sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000579 ↗ Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1994-09-01 The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
NCT00144846 ↗ Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children Completed GlaxoSmithKline Phase 3 2004-09-01 This study evaluates the effect of cumulative dose administration of albuterol sulfate inhalation aerosol delivered with valved holding chamber and facemask. This is a four week study in birth to 23 month old subjects who are experiencing acute wheezing due to obstructive airways disease.
NCT00394329 ↗ (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 2006-11-01 Asthma is a common, serious illness among children in the United States. It can be effectively controlled through the use of preventative medications and "rescue" medications, which are used to control symptoms. This study will evaluate the impact and severity of asthma exacerbations that occur in children with mild persistent asthma who are receiving various combinations of medications for daily and rescue use.
NCT00394329 ↗ (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) Completed Milton S. Hershey Medical Center Phase 3 2006-11-01 Asthma is a common, serious illness among children in the United States. It can be effectively controlled through the use of preventative medications and "rescue" medications, which are used to control symptoms. This study will evaluate the impact and severity of asthma exacerbations that occur in children with mild persistent asthma who are receiving various combinations of medications for daily and rescue use.
NCT00434993 ↗ Drug Study of Albuterol to Treat Acute Lung Injury Terminated National Heart, Lung, and Blood Institute (NHLBI) Phase 2/Phase 3 2007-08-01 Acute Respiratory Distress Syndrome (ARDS) and a lesser condition that occurs prior to ARDS, Acute Lung Injury (ALI), are medical conditions that occur when there is severe inflammation and increased fluids (edema) in both lungs, making it hard for the lungs to function properly. Patients with these conditions require treatment that includes the use of a breathing machine (ventilator). The purpose of this study is to find out whether giving albuterol (a drug commonly used in asthmatics) or not giving albuterol to patients with ALI or ARDS makes a difference in how long it takes for a patient to be able to breath without the ventilator.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for albuterol sulfate

Condition Name

Condition Name for albuterol sulfate
Intervention Trials
Asthma 18
Healthy 5
Pulmonary Disease, Chronic Obstructive 2
Respiratory Distress Syndrome, Adult 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for albuterol sulfate
Intervention Trials
Asthma 22
Lung Diseases 5
Pulmonary Disease, Chronic Obstructive 5
Lung Diseases, Obstructive 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for albuterol sulfate

Trials by Country

Trials by Country for albuterol sulfate
Location Trials
United States 193
Canada 4
Taiwan 3
United Kingdom 2
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for albuterol sulfate
Location Trials
California 16
Texas 13
North Carolina 12
Colorado 11
Florida 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for albuterol sulfate

Clinical Trial Phase

Clinical Trial Phase for albuterol sulfate
Clinical Trial Phase Trials
Phase 4 5
Phase 3 16
Phase 2/Phase 3 1
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for albuterol sulfate
Clinical Trial Phase Trials
Completed 27
Terminated 6
Recruiting 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for albuterol sulfate

Sponsor Name

Sponsor Name for albuterol sulfate
Sponsor Trials
AstraZeneca 5
Amphastar Pharmaceuticals, Inc. 3
National Heart, Lung, and Blood Institute (NHLBI) 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for albuterol sulfate
Sponsor Trials
Industry 33
Other 18
NIH 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKinsey
AstraZeneca
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.